Pleco Therapeutics Announces €8.7m Strategic Partnership with Hyloris
Pleco Therapeutics BV has announced a strategic partnership with Hyloris Pharmaceuticals SA. Pleco Therapeutics is a specialty biopharmaceutical company developing novel combination chelating agents to detoxify the cancer micro-environment. Hyloris Pharmaceuticals is a specialty